We anticipate that UK mid- and large-cap equities will fare much better in 2021 than they have in 2020, provided vaccines prove effective in winning the battle against COVID-19.
Subscriber content
Read this in full, free
Start a free trial and use one of your 10 free starter credits to unlock this piece.